OCUL
NASDAQ · Pharmaceuticals
Ocular Therapeutix Inc
$8.18
-0.09 (-1.09%)
Open$8.26
Previous Close$8.27
Day High$8.42
Day Low$8.04
52W High$16.44
52W Low$5.80
Volume—
Avg Volume6.95M
Market Cap1.93B
P/E Ratio—
EPS$-1.44
SectorPharmaceuticals
Analyst Ratings
Strong Buy
19 analysts
Price Target
+593.2% upside
Current
$8.18
$8.18
Target
$56.70
$56.70
$44.23
$56.70 avg
$95.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 52.17M | 52.02M | 384.00M |
| Net Income | -267,039,370 | -239,616,583 | 56.73M |
| Profit Margin | -511.9% | -486.3% | 14.8% |
| EBITDA | -266,757,346 | -252,661,494 | 95.97M |
| Free Cash Flow | — | — | 61.23M |
| Rev Growth | +0.3% | +0.3% | -3.5% |
| Debt/Equity | 0.11 | 0.11 | 0.35 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |